Annual ROE
-58.40%
-31.90%-120.38%
31 December 2023
Summary:
Lipocine annual return on equity is currently -58.40%, with the most recent change of -31.90% (-120.38%) on 31 December 2023. During the last 3 years, it has fallen by -56.32% (-2707.69%). LPCN annual ROE is now -108.60% below its all-time high of 678.76%, reached on 31 December 2012.LPCN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-19.17%
+17.24%+47.35%
30 September 2024
Summary:
Lipocine quarterly return on equity is currently -19.17%, with the most recent change of +17.24% (+47.35%) on 30 September 2024. Over the past year, it has increased by +39.65% (+67.41%). LPCN quarterly ROE is now -100.03% below its all-time high of 71.94 thousand%, reached on 31 March 2013.LPCN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPCN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +67.4% |
| 3 y3 years | -2707.7% | -936.2% |
| 5 y5 years | +64.7% | +86.5% |
LPCN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2707.7% | at low | -285.8% | +67.4% |
| 5 y | 5 years | -2707.7% | +69.9% | -285.8% | +91.0% |
| alltime | all time | -108.6% | +69.9% | -100.0% | +100.0% |
Lipocine ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -19.17%(-47.3%) |
| June 2024 | - | -36.41%(+3.4%) |
| Mar 2024 | - | -35.22%(-40.1%) |
| Dec 2023 | -58.40%(+120.4%) | -58.82%(+12.8%) |
| Sept 2023 | - | -52.15%(+50.2%) |
| June 2023 | - | -34.71%(+16.9%) |
| Mar 2023 | - | -29.70%(+11.1%) |
| Dec 2022 | -26.50%(+1174.0%) | -26.74%(-359.1%) |
| Sept 2022 | - | 10.32%(+18.5%) |
| June 2022 | - | 8.71%(-558.4%) |
| Mar 2022 | - | -1.90%(+2.7%) |
| Dec 2021 | -2.08%(-98.9%) | -1.85%(-97.1%) |
| Sept 2021 | - | -63.10%(-19.6%) |
| June 2021 | - | -78.47%(-22.3%) |
| Mar 2021 | - | -101.01%(-46.3%) |
| Dec 2020 | -193.85%(+17.2%) | -187.94%(-8.7%) |
| Sept 2020 | - | -205.94%(-3.6%) |
| June 2020 | - | -213.63%(+17.4%) |
| Mar 2020 | - | -181.92%(+27.6%) |
| Dec 2019 | -165.47%(+101.6%) | -142.53%(+12.6%) |
| Sept 2019 | - | -126.61%(+17.9%) |
| June 2019 | - | -107.35%(+13.5%) |
| Mar 2019 | - | -94.59%(+14.8%) |
| Dec 2018 | -82.07% | -82.43%(+1.9%) |
| Sept 2018 | - | -80.92%(-0.5%) |
| June 2018 | - | -81.30%(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -86.08%(-2.5%) |
| Dec 2017 | -110.55%(+51.6%) | -88.32%(+21.3%) |
| Sept 2017 | - | -72.84%(+14.5%) |
| June 2017 | - | -63.63%(+10.0%) |
| Mar 2017 | - | -57.84%(-0.9%) |
| Dec 2016 | -72.92%(+68.1%) | -58.36%(+3.4%) |
| Sept 2016 | - | -56.46%(-1.7%) |
| June 2016 | - | -57.45%(+3.2%) |
| Mar 2016 | - | -55.69%(+16.5%) |
| Dec 2015 | -43.37%(-43.9%) | -47.80%(-3.2%) |
| Sept 2015 | - | -49.36%(+6.8%) |
| June 2015 | - | -46.20%(-21.0%) |
| Mar 2015 | - | -58.47%(+0.8%) |
| Dec 2014 | -77.29%(+227.1%) | -58.02%(+3.4%) |
| Sept 2014 | - | -56.09%(-13.6%) |
| June 2014 | - | -64.95%(+19.6%) |
| Mar 2014 | - | -54.31%(+10.8%) |
| Dec 2013 | -23.63%(-103.5%) | -49.00%(-58.2%) |
| Sept 2013 | - | -117.23%(-100.2%) |
| June 2013 | - | 47.06 K%(-34.6%) |
| Mar 2013 | - | 71.94 K%(-104.9%) |
| Dec 2012 | 678.76%(-3336.8%) | -1.48 M%(+5797.6%) |
| Sept 2012 | - | -25.09 K%(+3568.6%) |
| June 2012 | - | -683.94%(+2749.8%) |
| Mar 2012 | - | -24.00% |
| Dec 2011 | -20.97% | - |
FAQ
- What is Lipocine annual return on equity?
- What is the all time high annual ROE for Lipocine?
- What is Lipocine quarterly return on equity?
- What is the all time high quarterly ROE for Lipocine?
- What is Lipocine quarterly ROE year-on-year change?
What is Lipocine annual return on equity?
The current annual ROE of LPCN is -58.40%
What is the all time high annual ROE for Lipocine?
Lipocine all-time high annual return on equity is 678.76%
What is Lipocine quarterly return on equity?
The current quarterly ROE of LPCN is -19.17%
What is the all time high quarterly ROE for Lipocine?
Lipocine all-time high quarterly return on equity is 71.94 K%
What is Lipocine quarterly ROE year-on-year change?
Over the past year, LPCN quarterly return on equity has changed by +39.65% (+67.41%)